David, P.; Kouhestani, D.; Hansen, F.J.; Paul, S.; Czubayko, F.; Karabiber, A.; Weisel, N.; Klösch, B.; Merkel, S.; Ole-Baur, J.;
et al. Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Int. J. Mol. Sci. 2025, 26, 1500.
https://doi.org/10.3390/ijms26041500
AMA Style
David P, Kouhestani D, Hansen FJ, Paul S, Czubayko F, Karabiber A, Weisel N, Klösch B, Merkel S, Ole-Baur J,
et al. Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 2025; 26(4):1500.
https://doi.org/10.3390/ijms26041500
Chicago/Turabian Style
David, Paul, Dina Kouhestani, Frederik J. Hansen, Sushmita Paul, Franziska Czubayko, Alara Karabiber, Nadine Weisel, Bettina Klösch, Susanne Merkel, Jan Ole-Baur,
and et al. 2025. "Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma" International Journal of Molecular Sciences 26, no. 4: 1500.
https://doi.org/10.3390/ijms26041500
APA Style
David, P., Kouhestani, D., Hansen, F. J., Paul, S., Czubayko, F., Karabiber, A., Weisel, N., Klösch, B., Merkel, S., Ole-Baur, J., Gießl, A., Van Deun, J., Vera, J., Mittelstädt, A., & Weber, G. F.
(2025). Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences, 26(4), 1500.
https://doi.org/10.3390/ijms26041500
